Cargando…
Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells
BACKGROUND: The low specificity of serum PSA resulting in the inability to effectively differentiate prostate cancer from benign prostate conditions is a persistent clinical challenge. The low sensitivity of serum PSA results in false negatives and can miss high‐grade prostate cancers. We describe a...
Autores principales: | Limaye, Sewanti, Chowdhury, Simon, Rohatgi, Nitesh, Ranade, Anantbhushan, Syed, Nelofer, Riedemann, Johann, Patil, Darshana, Akolkar, Dadasaheb, Datta, Vineet, Patel, Shoeb, Chougule, Rohit, Shejwalkar, Pradyumna, Bendale, Kiran, Apurwa, Sachin, Schuster, Stefan, John, Jinumary, Srinivasan, Ajay, Datar, Rajan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166919/ https://www.ncbi.nlm.nih.gov/pubmed/36718027 http://dx.doi.org/10.1002/cam4.5649 |
Ejemplares similares
-
Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
por: Crook, Timothy, et al.
Publicado: (2022) -
Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC
por: Ranade, Anantbhushan, et al.
Publicado: (2019) -
Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
por: Akolkar, Dadasaheb, et al.
Publicado: (2019) -
Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
por: Limaye, Sewanti, et al.
Publicado: (2021) -
Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers
por: Crook, Timothy, et al.
Publicado: (2021)